Scarlata, Simone, M.D.

Quick facts

Marketed products

• anti IL5 receptor antibodies · Immunology
  Anti-IL-5 receptor antibodies block the interleukin-5 receptor on eosinophils, preventing eosinophil activation and reducing eosinophilic inflammation.

Phase 1 pipeline

• Remifentanil TCI

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Scarlata, Simone, M.D. portfolio CI brief
• Scarlata, Simone, M.D. pipeline updates RSS